![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.235 | -4.94% | 4.52 | 4.35 | 4.69 | 4.75 | 4.36 | 4.75 | 212,429 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.50 | 9.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/8/2020 08:00 | Great post from Waterloo on the other thread: By Le Parisien with AFP On August 24, 2020 at 2:44 p.m. New treatments still in the trial phase will allow by "the end of the autumn" to improve the care of patients with Covid-19 in the hospital, estimated Monday the epidemiologist Arnaud Fontanet , member of the Scientific Council. "There are avenues around interferon-type treatments (proteins that interact with the immune system, editor's note) or treatments against these inflammatory molecules, cytokines, which seem really interesting," he said. on RMC-BFMTV. "These treatments are now in controlled trials with random draw," recalled the epidemiologist, saying he hopes they will be available "at the end of the fall". “I'm not saying that we will systematically cure all patients, no, but I think” that these drugs will allow “better results”, he added. | ![]() bignads | |
25/8/2020 07:57 | Wait for yesterday’s late reported trades. | ![]() wetdream | |
25/8/2020 07:40 | Well done Nobby, that stabilised things me thinks. | slinkyj | |
25/8/2020 07:38 | Yesterdays drop was nothing to worry about, it was all small trades, i did not see many over 5000, most were very small lower than 1000, if it was a concern there would be big numbers going threw and there was not so nothing to worry about. | ![]() readdin |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions